Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Reperfusion Therapy

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 134 participants.

Also called NCT06538844

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 134 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06538844
Other papers using this trial's data
  • Efficacy and safety of albumin combined with endovascular therapy in the treatment of patients with acute ischemic stroke: a randomized clinical trial Nature communications, 2026-04-20 DOI, PubMed 42010254, PMC13279982 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06538844. Randomized; double masking; primary purpose treatment. Start 2024-08-10 (actual); primary completion 2024-12-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Reperfusion Therapy
Condition
Acute Ischemic Stroke
Intervention (Drug)
Intravenous infusion of human albumin
Intervention (Drug)
Saline
Lead sponsor
Capital Medical University (class: other)
Collaborator
Xuanwu Hospital, Beijing (class: other)

Record details

Record id
cardio:ct-nct06538844
Content hash
ef9c6ae5cb6d7dfb7830889aeb63bc1d22f8791d6998edec26441e40fee77a26